A detailed history of Stephens Consulting, LLC transactions in Viatris Inc stock. As of the latest transaction made, Stephens Consulting, LLC holds 302 shares of VTRS stock, worth $3,926. This represents 0.0% of its overall portfolio holdings.

Number of Shares
302
Previous 302 -0.0%
Holding current value
$3,926
Previous $3.21 Million 9.22%
% of portfolio
0.0%
Previous 0.0%

Shares

6 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

Apr 17, 2024

BUY
$11.27 - $13.53 $552 - $662
49 Added 19.37%
302 $3.61 Million
Q4 2023

Feb 01, 2024

SELL
$8.77 - $10.85 $1,087 - $1,345
-124 Reduced 32.89%
253 $2.74 Million
Q2 2023

Jul 20, 2023

SELL
$9.02 - $10.29 $4,510 - $5,145
-500 Reduced 57.01%
377 $3.76 Million
Q2 2022

Jan 19, 2023

SELL
$9.95 - $12.27 $736 - $907
-74 Reduced 7.78%
877 $9.18 Million
Q1 2022

Jan 19, 2023

SELL
$9.81 - $15.4 $725 - $1,139
-74 Reduced 7.22%
951 $10.3 Million
Q4 2021

Jan 19, 2023

BUY
$12.09 - $14.68 $12,392 - $15,047
1,025 New
1,025 $13.9 Million

Others Institutions Holding VTRS

About Viatris Inc


  • Ticker VTRS
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 1,212,669,952
  • Market Cap $15.8B
  • Description
  • Viatris Inc. operates as a healthcare company worldwide. The company operates in four segments: Developed Markets, Greater China, JANZ, and Emerging Markets. It offers prescription brand drugs, generic drugs, complex generic drugs, biosimilars, and active pharmaceutical ingredients (APIs). The company offers drugs in various therapeutic areas, i...
More about VTRS
Track This Portfolio

Track Stephens Consulting, LLC Portfolio

Follow Stephens Consulting, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Stephens Consulting, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Stephens Consulting, LLC with notifications on news.